Nanalysis Scientific Corp.
NSCIF
$0.13
$0.016.08%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.60% | -6.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.60% | -6.24% | |||
| Cost of Revenue | 0.52% | -4.53% | |||
| Gross Profit | -12.34% | -11.21% | |||
| SG&A Expenses | -24.67% | 13.58% | |||
| Depreciation & Amortization | -15.53% | 19.20% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.99% | 1.58% | |||
| Operating Income | 36.05% | -79.30% | |||
| Income Before Tax | 30.86% | -78.34% | |||
| Income Tax Expenses | 147.15% | -166.67% | |||
| Earnings from Continuing Operations | 28.99% | -68.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.99% | -68.41% | |||
| EBIT | 36.05% | -79.30% | |||
| EBITDA | 36.66% | -91.21% | |||
| EPS Basic | 29.63% | -68.75% | |||
| Normalized Basic EPS | 35.63% | -81.25% | |||
| EPS Diluted | 34.48% | -81.25% | |||
| Normalized Diluted EPS | 35.63% | -81.25% | |||
| Average Basic Shares Outstanding | 1.13% | 0.28% | |||
| Average Diluted Shares Outstanding | 1.13% | 0.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||